| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 1.590 | 14.072 | 15.822 | 19.019 | 23.912 | 38.829 |
| Total Income - EUR | - | - | - | 0 | 1.590 | 14.072 | 15.822 | 19.019 | 23.912 | 38.829 |
| Total Expenses - EUR | - | - | - | 477 | 1.723 | 4.130 | 5.100 | 11.424 | 18.934 | 27.661 |
| Gross Profit/Loss - EUR | - | - | - | -477 | -133 | 9.943 | 10.722 | 7.595 | 4.979 | 11.168 |
| Net Profit/Loss - EUR | - | - | - | -477 | -181 | 9.557 | 10.248 | 7.132 | 4.775 | 10.178 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bgm Alergologie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 116 | 63 | 12 | 9.234 | 6.616 | 3.958 | 1.312 |
| Current Assets | - | - | - | 1.900 | 2.877 | 9.227 | 9.249 | 6.726 | 12.644 | 21.831 |
| Inventories | - | - | - | 1.760 | 1.705 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 156 | 150 | 3.563 | 2.585 | 5.581 | 3.540 |
| Cash | - | - | - | 140 | 1.016 | 9.077 | 5.686 | 4.141 | 7.063 | 18.291 |
| Shareholders Funds | - | - | - | -435 | -607 | 8.962 | 11.369 | 7.181 | 11.934 | 19.860 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.450 | 3.547 | 278 | 7.113 | 6.162 | 4.668 | 3.283 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bgm Alergologie S.r.l.